Universal Insurance Holdings Inc

UVE remains in a Stage 2 uptrend with higher highs and lows above rising EMAs and the 50-period SMA. It is consolidating within the 9/20-EMA and near-term resistance under neutral OB/OS and RSI conditions, showing no exhaustion. Medium-term bias stays bullish, but short-term timing requires patience. A pullback into the EMA/SMA confluence or a breakout above 44.33 would offer favorable buy engagement, while a sustained break below the 20-EMA and then the 50-SMA would invalidate the current uptrend.

• ↑Q2 adjusted EPS $1.84 (+49.6% YoY) and 33.2% ROE
• ↑Core revenue $419.4M (+4.6% YoY) and direct premiums $621.3M (+4.1%)
• ↓Net expense ratio climbed to 26.8% (+1.3 pts YoY), squeezing margins